CSR Compliance in India: A Practical Guide for Foreign-Owned Subsidiaries (2026–27)
Understand CSR obligations for foreign-owned Indian subsidiaries, including Section 135 thresholds, the 2% spending rule, ZCZP instruments and FY 2026–27 compliance.
Sister Ship Arrest in India: Ownership and Cross-Border Enforcement
Understand sister-ship arrest in India under the Admiralty Act, 2017, ownership requirements, foreign arbitral awards and cross-border enforcement.
How to Arrest a Ship in India: Procedure, Court Orders and Security
Learn how to arrest a ship in India, from filing an admiralty suit to executing the arrest order, obtaining security and releasing the vessel.
Ship Arrest in India: A Foreign Claimant’s Practical Guide — Part I
Understand ship arrest in India under the Admiralty Act, 2017, including maritime claims, High Court jurisdiction and key considerations for foreign claimants.
India Intellectual Property Law Update 2026: Key Developments in Patents, Trademarks, Copyright and Plant Variety Rights
Four rulings that together define India’s cross-practice IP posture in Q3 2026 — the Hon’ble Delhi High Court’s structured framework for Section 3(m) “mental acts”, the doctrinal reach of trans-border reputation of trademarks, the Hon’ble Supreme Court stay on communication-to-public licensing for in-room television of hotels, and the interaction between plant-variety enforcement and farmers’ rights.
India Corporate Law Update: CSR ZCZP Route, CCFS-2026 Amnesty & RBI TReDS Overhaul
Three regulatory updates from the Ministry of Corporate Affairs and the Reserve Bank of India that reshape how foreign companies manage CSR spending, compliance backlogs, and MSME receivables financing in India.
Recent Court Decisions in Arbitration
Three Supreme Court decisions and one Allahabad High Court decision delivered between April and July 2026
India Pharma & Life Sciences IP Update │ April–June 2026 Cases & Standards
From AbbVie’s Venetoclax setback to tougher impurity limits under Indian Pharmacopoeia 2026, this Q2 update distils the key patent, trademark and regulatory moves reshaping India’s pharma and life-sciences arena—and what they mean for your compliance strategy.
India’s IBC (Amendment) Act 2026 — What Foreign Counsel Should Know
India’s IBC (Amendment) Act, 2026 changes the way foreign creditors should assess Indian counterparty risk. From cross-border insolvency and group insolvency to CIIRP, mandatory admission timelines and guarantee enforcement, the Amendment reshapes recovery strategy for India-linked transactions.
Foreign Summary Judgments in India: 5 Clauses to Reread After Messer Griesheim case
This issue walks through what the Court actually said, why summary procedures in particular now fail the Indian enforceability test, the five contract clauses every foreign-counterparty agreement should be re-read against this month, and the choice between foreign-court and arbitration forums going forward. If you have an Indian counterparty in any of your cross-border contracts, […]